Navigation Links
Ex-Convicts From Tobacco-Free Prisons Need Help to Stay Off Smokes
Date:4/10/2013

WEDNESDAY, April 10 (HealthDay News) -- Inmates who quit smoking while in smoke-free prisons are more likely to stay tobacco free if they receive special counseling before they're released, new research suggests.

Interventions based on motivational interviewing and behavioral therapy improve smoking cessation rates among ex-convicts, according to a study published April 8 in the journal JAMA Internal Medicine.

The study, led by Dr. Jennifer Clarke, of Memorial Hospital of Rhode Island, involved nearly 300 inmates scheduled for release from a smoke-free prison in roughly eight weeks. Of the participants, 35 percent were women.

Each participant was randomly assigned to receive six weekly sessions of education videos or a behavioral intervention known as the WISE intervention (Working Inside for Smoking Elimination).

Three weeks after they were released from prison, 25 percent of the inmates assigned to the WISE intervention group remained tobacco free. In contrast, only 7 percent of those in the educational video group continued their smoking cessation, according to a journal news release.

The inmates who were smoke-free early on were reassessed at three months. By this point, 12 percent of the inmates from the WISE group and 2 percent of the educational video group remained tobacco-free.

Inmates who were Hispanic, who had a plan to avoid smoking and who had been in prison for more than six months were more likely to succeed in their attempt to stop smoking.

The study received funding from the U.S. National Institutes of Health/National Institute on Drug Abuse.

More information

The U.S. Centers for Disease Control and Prevention has more about tobacco use and smoking.

-- Mary Elizabeth Dallas

SOURCE: JAMA Internal Medicine, news release, April 8, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Ex-Convicts From Tobacco-Free Prisons Need Help to Stay Off Smokes
(Date:2/24/2017)... ... ... The International Association of Eating Disorders Professionals (iaedp) announces the 2017 top five ... art competition. Selected from 15 submissions from around the nation, the top five finalists ... iaedp Symposium, March 22 – 26 in Las Vegas. , This year, the competition ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... specializes in thought leadership , media relations, social media, content marketing and ... will be powered through Act-On, an intuitive marketing automation platform. , Rosica will ...
(Date:2/23/2017)... Austin, TX (PRWEB) , ... February 23, 2017 ... ... has announced an official 2017 partnership with The Jensie Gran Fondo of Marin. ... UVA and UVB rays with Thinksport’s broad-spectrum, mineral-based sunscreen. , “We are thrilled ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through ... return to the La Gorce Country Club in Miami Beach to host its ...
(Date:2/23/2017)... ... 2017 , ... Los Angeles-based weight loss surgeon Michael Feiz, M.D., F.AC.S. will ... to Hot,” which will begin airing on February 24, 2017. The show chronicles the ... 2012 reality television series, “Here Comes Honey Boo Boo.” The earlier series from TLC ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... YORK , Feb. 24, 2017 ... Monteverde & Associates PC , a boutique securities firm ... New York City , announces that a class ... Massachusetts  against Inotek Pharmaceuticals Corporation ... of the Company,s securities between July 23, 2015 and December ...
(Date:2/24/2017)...  Directors from Pharma To Market Pty Ltd and Ador Consulting ... in the founding of Pharma To Market Pte Ltd, based in ... pleased to announce their expansion into Asia ... . The company are delighted to appoint Joelle Chia , ... Singapore based entity. Joelle brings with her an extensive ...
(Date:2/24/2017)...  Xynomic Pharmaceuticals, Inc., an oncology drug research ... acquired exclusive worldwide rights to develop, manufacture and ... targeting hematological and solid tumors. To ... 2 clinical trials of Abexinostat in US, EU ... been completed, demonstrating that Abexinostat is clinically active ...
Breaking Medicine Technology: